Nurix Therapeutics, Inc.

Ensign Peak Advisors, Inc NRIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

230,828

Value ($000)

4,379

Weight

0.0%

2020 Q3 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	4,379	0.0%	230,828	12/31/2025
2025 Q3	11/13/2025	2,133	0.0%	230,828	9/30/2025
2025 Q2	8/12/2025	2,629	0.0%	230,828	6/30/2025
2025 Q1	5/14/2025	2,742	0.0%	230,828	3/31/2025
2024 Q4	2/14/2025	7,059	0.0%	374,673	12/31/2024
2024 Q3	11/14/2024	4,045	0.0%	180,000	9/30/2024
2024 Q2	8/13/2024	744	0.0%	35,644	6/30/2024
2024 Q1	5/14/2024	1,175	0.0%	79,907	3/31/2024
2023 Q4	2/14/2024	825	0.0%	79,907	12/31/2023
2023 Q3	11/13/2023	628	0.0%	79,907	9/30/2023
2023 Q2	8/14/2023	798	0.0%	79,907	6/30/2023
2023 Q1	5/15/2023	710	0.0%	79,907	3/31/2023
2022 Q4	2/13/2023	877	0.0%	79,907	12/31/2022
2022 Q3	11/14/2022	1,133	0.0%	86,967	9/30/2022
2022 Q2	8/12/2022	1,074	0.0%	84,797	6/30/2022
2022 Q1	5/16/2022	1,188	0.0%	84,797	3/31/2022
2021 Q4	2/11/2022	142	0.0%	4,890	12/31/2021
2021 Q3	11/12/2021	24	0.0%	799	9/30/2021
2021 Q2	8/13/2021	21	0.0%	799	6/30/2021
2021 Q1	5/12/2021	25	0.0%	799	3/31/2021
2020 Q4	2/12/2021	26	0.0%	799	12/31/2020
2020 Q3	11/12/2020	28	0.0%	799	9/30/2020